Louisville, KY, United States of America

Gilles Hugues Tapolsky

USPTO Granted Patents = 25 

 

Average Co-Inventor Count = 3.7

ph-index = 7

Forward Citations = 596(Granted Patents)


Location History:

  • The Woodlands, TX (US) (1998 - 2009)
  • Boulder, CO (US) (2012 - 2013)
  • Louisville, KY (US) (2013 - 2024)

Company Filing History:


Years Active: 1998-2024

Loading Chart...
Loading Chart...
25 patents (USPTO):Explore Patents

Title: Innovations in Oncology: The Contributions of Gilles Hugues Tapolsky

Introduction

Gilles Hugues Tapolsky, based in Louisville, KY, has made significant advancements in the field of oncology through his innovative research and numerous patents. With a total of 25 patents to his name, his work primarily focuses on the development of biologically active compounds for cancer treatment.

Latest Patents

Among his latest patents are noteworthy inventions that aim to improve cancer therapies. One such patent is for "Biologically active taxane analogs and methods of treatment by oral administration." This invention pertains to a novel chemical compound used for treating cancer, including compositions that incorporate this compound. The patent describes methods of manufacture and the potential for combinations with other therapeutic agents. Another significant patent is related to "Taxane analogs for the treatment of brain cancer." This patent outlines compounds and methods specifically designed for administering to mammals, which stabilize tubulin dimers or microtubules at the G2-M interface during mitosis—crucial for the effective treatment of brain cancer.

Career Highlights

Throughout his career, Gilles Hugues Tapolsky has contributed to various esteemed organizations, including Tapestry Pharmaceuticals, Inc. and Virotex Corporation. His innovative approach and dedication to cancer research have positioned him as a prominent figure in the pharmaceutical industry.

Collaborations

Collaboration has been key to Tapolsky's research endeavors. He has worked alongside notable colleagues such as James D. McChesney and John L. Marshall. Their collective expertise has facilitated the development of groundbreaking treatments that hold promise for cancer patients.

Conclusion

Gilles Hugues Tapolsky's contributions to cancer research through innovative patents and collaborations highlight his commitment to improving treatment outcomes. His pioneering work in taxane analogs and the development of novel therapeutic agents reflects the potential of innovation in transforming cancer therapies, underscoring the importance of continued research in this critical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…